Trial Profile
SNP analysis of brexpiprazole-treated Japanese schizophrenia patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Mar 2021
Price :
$35
*
At a glance
- Drugs Brexpiprazole (Primary)
- Indications Schizophrenia
- Focus Pharmacodynamics
- Sponsors Otsuka Pharmaceutical
- 08 Mar 2021 Status changed from active, no longer recruiting to completed.
- 04 Apr 2018 New trial record